Health Canada drug identification number

DIN 02351722 — FLUDARABINE PHOSPHATE INJECTION 25 MG

FLUDARABINE PHOSPHATE INJECTION is a solution of Fludarabine marketed by FRESENIUS KABI CANADA LTD. The full Fludarabine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02351722
Brand name
FLUDARABINE PHOSPHATE INJECTION
Active ingredient
Fludarabine
Strength
25 MG
Dosage form
SOLUTION
Route
INTRAVENOUS
Manufacturer
FRESENIUS KABI CANADA LTD
Health Canada status
DORMANT
Drug class
Purine nucleoside analogue antineoplastic (antimetabolite chemotherapy agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Fludarabine products

DINBrandStrengthFormManufacturerStatus
02246226 FLUDARA 10 MG TABLET SANOFI-AVENTIS CANADA INC MARKETED
02283859 FLUDARABINE PHOSPHATE FOR INJECTION 25 MG SOLUTION TEVA CANADA LIMITED MARKETED
02438577 FLUDARABINE PHOSPHATE INJECTION, USP 25 MG SOLUTION ACCORD HEALTHCARE INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.